DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Cadavid D, Balcer L, Galetta S. et al.
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial.
Lancet Neurol 2017;
16: 189-199
doi:10.1016/S1474-4422(16)30377-5
We do not assume any responsibility for the contents of the web pages of other providers.